Hong-Yu Peng
Overview
Explore the profile of Hong-Yu Peng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu W, Wang W, Li C, Xiong H, Ma Y, Luo M, et al.
Curr Med Sci
. 2019 Oct;
39(5):843-851.
PMID: 31612406
Throughout the duration of the New Cooperative Medical Scheme (NCMS), it was found that an increasing number of rural patients were seeking out-of-county medical treatment, which posed a great burden...
2.
Ma C, Xu Z, Wang S, Peng H, Liu F, Liu J, et al.
Chin Med J (Engl)
. 2018 Jun;
131(12):1444-1449.
PMID: 29893361
Background: Acute coronary syndrome (ACS) is closely related to unstable plaques and secondary thrombosis. The inflammatory cells in plaques and their inflammatory products may be the cause for plaque instability...
3.
Ma C, Liu J, Liu J, Shi D, Xu Z, Wang S, et al.
Chin J Integr Med
. 2016 Dec;
23(11):845-849.
PMID: 28028722
Objective: To investigate the relationship between inflammatory factors and two Chinese medicine (CM) syndrome types of qi stagnation and blood stasis (QSBS) and qi deficiency and blood stasis (QDBS) in...
4.
Zheng X, Zhao D, Peng H, Fan Q, Ma Q, Xu Z, et al.
Chin Med J (Engl)
. 2016 Feb;
129(5):505-10.
PMID: 26904982
Background: The crush and the culotte stenting were both reported to be effective for complex bifurcation lesion treatment. However, their comparative performance remains elusive. Methods: A total of 300 patients...
5.
Chen M, Zheng B, Wu Z, Peng H, Wang X, Zhang B, et al.
Chin Med J (Engl)
. 2013 Dec;
126(24):4731-5.
PMID: 24342320
Background: Drug-eluting stents represent a major advance in interventional cardiology. However, the current drug-eluting stents have significant limitations. One of the major problems is very late stent thrombosis, which is...
6.
Liu C, Yan H, Zhao H, Song L, Zheng B, Chi Y, et al.
Chin Med J (Engl)
. 2013 Feb;
126(3):446-9.
PMID: 23422105
Background: Repeat percutaneous coronary intervention (PCI) is associated with unfavorable prognosis in patients with coronary artery disease, but there is a current lack of related systematic cross-sectional studies in China....
7.
Chen M, Wang X, Zheng B, Peng H, Zhang X, Zhang B, et al.
Chin Med J (Engl)
. 2012 Nov;
125(22):4083-7.
PMID: 23158147
Background: Stent-based delivery of sirolimus has been shown to reduce neointimal hyperplasia significantly. However, the long-term effect of the polymer is thought to initiate and sustain an inflammatory response and...
8.
Peng H, Chen M, Zheng B, Wang X, Huo Y
Int Heart J
. 2009 Dec;
50(6):811-22.
PMID: 19952477
The postulated relationship between nonbiodegradable polymers and late stent thrombosis has led to a concerted effort to seek alternative biodegradable polymers for drug delivery. The purpose of this study was...
9.
Mei C, Chen Z, Liao Y, Wang Y, Peng H, Chen Y
Cell Biol Int
. 2007 Aug;
31(12):1456-61.
PMID: 17689273
It is suggested that cholesterol efflux mediated by ATP binding cassette transporter A1 (ABCA1) plays an important role in anti-atherogenesis. However, the effects of inflammatory cytokines on ABCA1 expression and...